44 results on '"Horninger, Wolfgang"'
Search Results
2. Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response
3. Do we need repeated CT imaging in uncomplicated blunt renal injuries? Experiences of a high-volume urological trauma centre
4. Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma
5. Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients
6. Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
7. The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
8. Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival
9. Incidental resection of a scrotal aggressive angiomyxoma mimicking a spermatocele: a case report
10. The impact of surgery in oligometastatic prostate cancer
11. Lutetium-PSMA therapy—a new therapeutic option in metastatic castration-resistant prostate cancer?
12. ASCO 2018: highlights of urothelial cancer and prostate cancer
13. Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy
14. Adenomatoid tumor of the testis mimicking malignant testicular cancer on multiparametric ultrasound
15. Aktueller Stand der multiparametrischen MRT
16. Aktueller Stand der multiparametrischen MRT
17. Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model
18. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence
19. 68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
20. The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
21. Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions
22. Long term disease free survival with multimodal therapy in small cell bladder cancer
23. 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
24. Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot
25. 68Ga-PSMA ligand PET versus 18F-NaF PET: evaluation of response to 223Ra therapy in a prostate cancer patient
26. Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis
27. Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer
28. Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?
29. Organ-sparing surgery is the treatment of choice in benign testicular tumors
30. Local therapy in prostate cancer—surgery versus radiation
31. Prevalence of the human papillomavirus (HPV) expression of the inner prepuce in asymptomatic boys and men
32. Autologous fibroblast transplantation at the vesico-ureteral junction as potential reconstructive cell replacement in an animal model
33. Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group
34. Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group
35. Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
36. Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: a retrospective data analysis
37. Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008
38. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection
39. How should PSA screening efforts be focused to prevent underdiagnosis and overdiagnosis of prostate cancer?
40. Single-Institution Results of Primary External-Beam Radiation for the Treatment of T1–T3 Prostate Cancer
41. Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection
42. Nerve-sparing during robotic radical prostatectomy: Use of computer modeling and anatomic data to establish critical steps and maneuvers
43. Screening for prostate cancer: updated experience from the tyrol study
44. Screening for prostate cancer: Updated experience from the Tyrol study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.